Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Minneapolis | 338 Studies

Clinical Trials Breast CancerMinneapolis

Breast Cancer Clinical Trials in Minneapolis

Find 338 clinical trials for breast cancer near Minneapolis, Minnesota. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Minneapolis

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 181-200 of 338 trials

CompletedStudy of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Participants With HR+/HER2- Metastatic Breast CancerThe primary objective of this study is to assess and compare the efficacy and safety of sacituzumab govitecan-hzi versus treatment of physician's choice (TPC) in participants with…NCT03901339·Avondale, Arizona and 112 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedDocetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast CancerRATIONALE: Drugs used in chemotherapy, such as docetaxel and carboplatin, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them…NCT00820872·Scottsdale, Arizona and 135 others

CompletedA Study of Tucatinib vs. Placebo in Combination With Capecitabine & Trastuzumab in Patients With Advanced HER2+ Breast CancerThis study is being done to see if tucatinib works better than placebo to help patients who have a specific type of breast cancer called HER2 positive breast carcinoma.NCT02614794·Birmingham, Alabama and 175 others

Active not recruitingComparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyThis randomized phase III trial studies lymph node dissection and radiation therapy to see how well it works compared to radiation therapy alone in treating patients with breast…NCT01901094·Daphne, Alabama and 1245 others

CompletedInterleukin-12 in Treating Patients With Metastatic or Recurrent Breast CancerRATIONALE: Interleukin-12 may kill tumor cells by stopping blood flow to the tumor and by stimulating a person's white blood cells to kill breast cancer cells.NCT00004893·Birmingham, Alabama and 48 others

CompletedA Study of Ramucirumab (IMC-1121B) in Combination With Eribulin Versus Eribulin Alone in Participants With Breast CancerThis is a study to compare the antitumor activity of ramucirumab (IMC-1121B) and eribulin together versus eribulin alone, in participants with locally recurrent or metastatic…NCT01427933·Birmingham, Alabama and 51 others

RecruitingTesting Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low TrialThis phase III trial compares standard of care hormone therapy plus ribociclib to chemotherapy followed by hormone therapy plus ribociclib for the treatment of patients with high…NCT07391774·Jonesboro, Arkansas and 257 others

CompletedS0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With ChemoRATIONALE: Drugs used in chemotherapy work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing.NCT00382018·Anniston, Alabama and 295 others

Active not recruitingTargeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple…NCT02465060·Birmingham, Alabama and 1409 others

TerminatedA Phase 2 Study of EZN-2208 in Patients With Metastatic Breast CancerThis is a Phase 2, multicenter, open-label, noncomparative study to evaluate safety,efficacy and of single-agent EZN 2208 administered in patients with previously treated MBC.NCT01036113·Sedona, Arizona and 35 others

RecruitingMammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression ProfilesThe FLEX Registry will be implemented to operate as a large-scale, population based, prospective registry.NCT03053193·Birmingham, Alabama and 133 others

TerminatedEvaluation of Mammographic Breast Density in Participants with Hormone Receptor-Negative Breast Cancer Enrolled on Study A011502This phase III trial evaluates mammographic breast density in participants with hormone receptor-negative breast cancer enrolled on study A011502.NCT03609021·Fairbanks, Alaska and 514 others

Active not recruitingPhase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast CancerThis is a Phase 1b open-label, 2-part study in 4 treatment groups.NCT05508906·Gilbert, Arizona and 15 others

CompletedRaloxifene Use for The HeartThe purpose of this study is to determine whether raloxifene compared with placebo lowers the risk of coronary events and reduces the risk of invasive breast cancer in…NCT00190593·Minneapolis, Minnesota

RecruitingcfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseThis is an observational case-control study to train and validate a genome-wide methylome enrichment platform to detect multiple cancer types and to differentiate amongst cancer…NCT05366881·Duarte, California and 16 others

CompletedRadiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone LumpectomyThis randomized phase III trial studies radiation therapy to see how well it works with or without trastuzumab in treating women with ductal carcinoma in situ who have undergone…NCT00769379·Anniston, Alabama and 1259 others

Active not recruitingLow-Dose Tamoxifen Citrate in Reducing Breast Cancer Risk in Radiation-Induced Cancer SurvivorsEstrogen can cause the growth of breast cancer cells.NCT01196936·Birmingham, Alabama and 12 others

Active not recruitingDoxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerThis randomized phase III trial studies how well doxorubicin hydrochloride and cyclophosphamide followed by paclitaxel with or without carboplatin work in treating patients with…NCT02488967·Mobile, Alabama and 1295 others

CompletedEarly Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast CancerRATIONALE: The primary tumor might be a source of re-seeding of distant sites and therefore elimination of this source of metastasizing cells by early local therapy may be of…NCT01242800·Mobile, Alabama and 376 others

TerminatedLong-term, Non-interventional, Observational Study Following Treatment With Fate Therapeutics FT500 Cellular ImmunotherapySubjects who previously took part in the FT500-101 study and received allogeneic NK cell immunotherapy will take part in this long term follow-up study.NCT04106167·San Diego, California and 3 others

PreviousPage 10 of 17Next

Other Conditions in Minneapolis

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma